DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PH-797804

« Back to Dashboard

Clinical Trials for PH-797804

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00383188	An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis	Completed	Pfizer	Phase 2	Investigating the safety and tolerability of a p38 inhibitor as monotherapy in subjects who have failed at least 1 DMARD.
NCT00559910	A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).	Completed	Pfizer	Phase 2	PH-797804 is a potent ant-inflammatory drug that may reduce the inflammation that is associated with COPD. PH-797804 will be dosed to patients with COPD to evaluate its potential safety and efficacy profile in COPD.
NCT00614705	PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia	Completed	Pfizer	Phase 2	This is a proof-of-concept study to determine if PH-797804 reduces neuropathic pain associated with post-herpetic neuralgia. Suitable patients will be randomized to receive either PH-797804 or placebo for 4 weeks, during which time they will also record their pain symptoms using various pain scales.
NCT00620685	A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate	Completed	Pfizer	Phase 2	The hypothesis of this study is that the p38 inhibitor (PH-797804) will be safe and well tolerated in subjects with rheumatoid arthritis who are taking methotrexate and will not effect the blood levels of methotrexate.

Clinical Trial Conditions for PH-797804

Condition Name

Condition Name for
Intervention	Trials
Healthy	5
Pulmonary Disease, Chronic Obstructive	2
Arthritis, Rheumatoid	2
Healthy Volunteers	1

Condition MeSH

Condition MeSH for
Intervention	Trials
Pulmonary Disease, Chronic Obstructive	4
Lung Diseases, Obstructive	4
Lung Diseases	4
Arthritis, Rheumatoid	2

Clinical Trial Locations for PH-797804

Trials by Country

Trials by Country for
Location	Trials
United States	54
South Africa	12
Canada	12
Japan	10
United Kingdom	9

Trials by US State

Trials by US State for
Location	Trials
Florida	4
California	3
Arizona	3
Texas	3
South Carolina	3

Clinical Trial Progress for PH-797804

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 2	7
Phase 1	7

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	13
Withdrawn	1

Clinical Trial Sponsors for PH-797804

Sponsor Name

Sponsor Name for
Sponsor	Trials
Pfizer	14

Sponsor Type

Sponsor Type for
Sponsor	Trials
Industry	14